Telix Pharmaceuticals and Pharmalogic Enter US Distribution Agreement for Prostate Cancer Imaging
Indianapolis IN and Boca Raton FL (U.S.A) – 15th May 2020. Telix Pharma (U.S.) announces it has entered into a commercial...
The Seneffe Manufacturing Site – Telix’s Next Big Move in Europe
1st May 2020 - Corporate Spotlight | Telix’s CEO Chris Behrenbruch comments on the Company’s next big move in Europe...
Seneffe Manufacturing Facility – Shareholder Walkthrough
Melbourne (Australia) 28 April 2020 - Telix Pharmaceuticals Limited provides a shareholder walkthrough of it's recently acquired Seneffe manufacturing facility
Telix presents IPAX-1 study in glioblastoma treatment at ASCO 2020
25th May 2020 - Clinical Spotlight | Telix Presents the IPAX-1 Study at the American Society of Clinical Oncology (ASCO)
Telix Pharmaceuticals Granted July Pre-IND Meeting with US FDA for Phase III ProstACT Study
Melbourne (Australia)– 14th May 2020. Telix has been granted a Type B pre-IND meeting with the FDA in relation to...